PALI · Palisade Bio, Inc.
$2.10
+0.04 (+1.94%)
At close · Aug 21
Market Cap
$365.97M
Shares
174.27M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| J.D. Finley | Chief Executive Officer and Chief Financial Officer | $813,000 |
| Mitchell Jones | M.D., Ph.D. Chief Medical Officer | $581,000 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| J.D. Finley | Chief Executive Officer and Chief Financial Officer | $1,277,100 |
| Mitchell Jones | M.D., Ph.D. Chief Medical Officer | $458,024 |
| Robert McRae | Chief Operating Officer | $199,422 |
| Michael J. Dawson | Former Chief Medical Officer | — |
| Thomas Hallam | Former Chief Executive Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| J.D. Finley | Chief Executive Officer and Chief Financial Officer | $613,561 |
| Thomas Hallam | Former Chief Executive Officer | $533,822 |
| Robert McRae | Chief Operating Officer | $500,487 |
| Michael J. Dawson | Former Chief Medical Officer | $189,180 |
| Herbert Slade | MD, FAAAAI Chief Medical Officer | $59,063 |
| Mitchell Jones | M.D., Ph.D. Chief Medical Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Kenneth Carter | Executive Chairman Dane Saglio | $1,460,472 |
| Thomas Hallam | Former Chief Executive Officer | $1,394,867 |
| J.D. Finley | Chief Executive Officer and Chief Financial Officer | $1,112,705 |
| Michael J. Dawson | Former Chief Medical Officer | $235,596 |
| Robert McRae | Chief Operating Officer | $62,153 |
| Herbert Slade | MD, FAAAAI Chief Medical Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Kenneth Carter | Executive Chairman Dane Saglio | $902,364 |
| Matthew Kalnik | Chief Operating Officer and President | $822,632 |
| Thomas Hallam | Chief Executive Officer | $769,035 |
| J.D. Finley | Chief Financial Officer | $531,722 |
| Dane Saglio | Chief Financial Officer | $520,816 |
| Michael J. Dawson | Chief Medical Officer | $183,290 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Kenneth Carter | Executive Chairman | $840,409 |
| Matthew Kalnik | Chief Operating Officer and President | $358,750 |
| Dane Saglio | Chief Financial Officer | $84 |
| James Scully | Former Chief Executive, President | — |
| Richard J. Daly | Former Chief Executive, President | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| James Scully | Former Chief Executive, President | $400,035 |
| Richard J. Daly | Former Chief Executive, President | $385,537 |
| Matthew Kalnik | Chief Operating Officer and President | — |
| Kenneth Carter | PhD, Executive Chairman | — |
| Dane Saglio | Chief Financial Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Robert F. Baltera, Jr. | Director | Appointed | 2026-06-11 |
| Emil Chuang | Director | Appointed | 2026-06-11 |
| Donald Williams | Director | Appointed | 2026-06-11 |
| J.D. Finley | Director | Appointed | 2026-06-11 |
| Jordan Zwick | Director | Appointed | 2026-06-11 |
| Emil Chuang | director | Appointed | 2025-07-09 |
| Margery Fischbein | director | Resigned | 2025-07-09 |
| Margery Fischbein | Board of Directors | Appointed | 2024-05-10 |
| Mary Ann Gray, Ph.D. | member of the Board | Resigned | 2024-03-06 |
| Dr. Cristina Csimma | member of the Board | Resigned | 2024-02-13 |
| Dr. Robert Trenschel | member of the Board | Resigned | 2024-02-13 |
| Stephanie Diaz | member of the Board | Resigned | 2024-02-13 |
| James Neal | member of the Board | Resigned | 2024-02-13 |
| Mitchell Jones, M.D., Ph.D. | Chief Medical Officer | Appointed | 2023-09-11 |
| J.D. Finley | Board of Directors | Appointed | 2023-02-08 |
| Robert McRae | Chief Operating Officer | Appointed | 2023-02-08 |
| Herbert B. Slade | Chief Medical Officer | Appointed | 2022-11-23 |
| Michael Dawson, MD | Chief Medical Officer | Terminated | 2022-10-17 |
| J.D. Finley | interim Chief Executive Officer | Appointed | 2022-10-14 |
| Thomas Hallam, Ph.D. | member of the Board of Directors | Resigned | 2022-10-14 |
| Thomas Hallam, Ph.D. | Chief Executive Officer | Resigned | 2022-10-14 |
| Thomas Hallam, Ph.D. | Chief Executive Officer (principal executive officer) | Appointed | 2021-04-27 |
| Michael Dawson, M.D. | Chief Medical Officer | Appointed | 2021-04-27 |
| J.D. Finley | Chief Financial Officer (principal financial and accounting officer) | Appointed | 2021-04-27 |
| Don Williams | Director | Appointed | 2021-04-27 |
Key facts
CIK
1357459
CUSIP
696389402
13F (30d)
122 filings
121 filers
Visit website
Investor relations